Indo-MIM IPO 2026: GMP, Price Band, Subscription & Listing Date

The Indo-MIM IPO closes today, July 27, 2026. It’s priced at ₹461–₹485 a share, and on the final day it was commanding a grey market premium (GMP) of about ₹190 — roughly 39% above the top of the band. Shares are set to list on July 30 on both the NSE and BSE.

So if you were waiting till the last minute to decide, here’s the quick, honest rundown.

Key Takeaways

  • Price band: ₹461–₹485; lot of 30 shares (about ₹14,550 minimum)
  • Issue size: ₹3,812 crore — mostly an Offer for Sale, not fresh capital
  • GMP today: ~₹190 (~39% over the ₹485 top price)
  • Dates: bidding Jul 23–27, allotment Jul 28, listing Jul 30 (NSE & BSE)

Indo-MIM IPO details at a glance

Detail Value
Price band ₹461 – ₹485 per share
Lot size 30 shares (~₹14,550)
Total issue ₹3,812 crore (fresh ₹499 cr + OFS ₹3,311 cr)
GMP (27 Jul) ~₹190 (~39%)
Subscription Jul 23 – Jul 27, 2026
Allotment Jul 28, 2026
Listing Jul 30, 2026 (NSE & BSE)

What does that ₹190 GMP actually tell you?

On paper, a ₹190 grey market premium points to a listing near ₹675 — a tidy ~39% pop over the ₹485 issue price. That’s what built the buzz through the week.

But here’s the part worth remembering: the GMP is an unofficial, word-of-mouth number. It moves by the hour and carries no legal standing. Plenty of IPOs have shown a fat premium on the last day that thinned out badly by listing morning. Treat it as sentiment, not a promise.

What does Indo-MIM actually do?

Founded in 1996, Indo-MIM is a precision-manufacturing company. Its specialty is Metal Injection Molding (MIM) — a process for making small, complex, high-strength metal parts — alongside investment casting and additive manufacturing.

Those parts feed into automotive, aerospace, defence and medical devices worldwide. In plain terms, it’s a niche engineering supplier, not a consumer brand you’d recognise on a shelf.

Should you apply on the last day?

One number should give retail investors pause: this issue is mostly an Offer for Sale. Of the ₹3,812 crore, only about ₹499 crore is fresh money going into the business — the rest is existing shareholders cashing out. That isn’t automatically a red flag, but it means you’re largely buying stock from sellers, not funding the company’s growth.

Chasing the listing pop means betting sentiment holds for 72 hours. For a long-term investor, valuation and fundamentals matter far more than today’s GMP. And if IPOs feel like a gamble, that’s a fair instinct — building a base through steady index-fund investing is a calmer place to start before punting on individual listings.

How to check your Indo-MIM IPO allotment

Allotment is expected on July 28. Once it’s finalised, you can check your status two ways: on the registrar’s website by entering your PAN or application number, or on the BSE IPO page under the “Equity” section. If shares are allotted, they’ll show up in your demat account by listing day; if not, the blocked UPI amount is released back to you automatically.

One practical tip: keep your application number or DP/client ID handy before allotment day. These registrar sites get hammered with traffic the moment results drop, and having your details ready makes the lookup far quicker.

Frequently Asked Questions

What is the Indo-MIM IPO GMP today?
About ₹190 per share as of July 27, 2026 — roughly 39% above the ₹485 upper price band.

What is the price band and lot size?
₹461–₹485 per share, with a minimum lot of 30 shares (around ₹14,550 at the top price).

When is the Indo-MIM IPO allotment and listing date?
Allotment is expected on July 28, 2026, and listing on July 30, 2026 on the NSE and BSE.

Is it a fresh issue or an offer for sale?
Mostly an Offer for Sale (about ₹3,311 crore), with a smaller fresh issue of roughly ₹499 crore.

The bottom line

The Indo-MIM IPO is a solid, if unglamorous, precision-engineering play arriving on a wave of grey-market optimism. The ₹190 GMP is encouraging, but it’s a mood, not a guarantee — and the OFS-heavy structure means most of your money isn’t going into the company itself. Decide on the business, not the buzz.

Leave a Reply

Your email address will not be published. Required fields are marked *